Report cover image

Israel Pharmaceuticals Market Size study, by Drug Type (Generic and Branded Drugs), by Product Type (Over-The-Counter Drugs, Prescription Drugs), by Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, Others), by Di

Publisher Bizwit Research & Consulting
Published Aug 05, 2024
Length 285 Pages
SKU # BIZW19056016

Description

Israel Pharmaceuticals Market Size study, by Drug Type (Generic and Branded Drugs), by Product Type (Over-The-Counter Drugs, Prescription Drugs), by Application (Cardiovascular, Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, Others), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), and Forecasts 2022-2032


Israel Pharmaceuticals Market is valued at approximately USD 2.97 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2024-2032. Israel stands as the fourth-largest supplier of pharmaceutical products globally, a status attributed to its significant financial investments in research and development (R&D) and its impressive international reach. The market's expansion is underpinned by the rising prevalence of non-communicable diseases such as cancer, diabetes, and cardiac disorders, necessitating advanced pharmaceutical solutions.

The prevalence of chronic diseases, defined as conditions lasting more than a year and requiring ongoing medical attention, is a major factor driving the market. Cancer, diabetes, and cardiac disorders are particularly prevalent, with cancer being the leading cause of mortality in Israel. Every year, approximately 30,000 people are diagnosed with cancer, contributing to 25% of the annual death rate. Similarly, cardiovascular diseases account for about 15% of deaths per year. Diabetes, especially Type 2 diabetes mellitus, is also widespread due to factors like physical inactivity, genetic predispositions, and obesity. The rising cases of these chronic diseases increase the demand for pharmaceutical products, driving market growth.

Government initiatives and health education programs are crucial in promoting healthcare awareness and encouraging healthy lifestyles. Programs like the Israeli Health Promoting School Network (HPSN) aim to enhance healthy living among the school population. The government is also advancing healthcare technologies and focusing on R&D to produce innovative pharmaceutical products. These initiatives are expected to further propel the market growth. Israel's advanced healthcare system, ranked tenth globally, provides affordable healthcare services to all citizens under the National Health Insurance law. This accessibility makes pharmaceutical products more affordable, fueling market growth. Additionally, the growing geriatric population, which is more prone to chronic diseases, contributes to the increasing demand for pharmaceutical products. Recent developments in the market include significant investments by pharmaceutical giants like Pfizer Pharmaceuticals Israel Ltd. in Israeli firms for drug R&D. Innovative drugs like Doxil and Copaxone, developed by Israeli researchers, have gained global recognition, further boosting the market. However, financial hurdles for consumers and manufacturers and competition from international pharmaceutical companies would hamper the market growth.

Major market players included in this report are:

Teva Pharmaceutical Industries Ltd

Kamada Pharmaceuticals

MediWound Ltd

Protalix BioTherapeutics Inc

Enlivex Therapeutics Ltd

Bonus BioGroup Ltd

Roche Pharmaceuticals (Israel) Ltd.

Rafa Laboratories Ltd.

Pfizer Pharmaceuticals Israel Ltd.

CytoReason

Dexcel Pharma

Pharmathen

Sanofi (Israel)

Novartis Israel

Merck Sharp & Dohme (Israel)

The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Generic Drugs

Branded Drugs

By Product Type:

Over-The-Counter Drugs

Prescription Drugs

By Application:

Cardiovascular

Oncology

Metabolic Disorder

Musculoskeletal

Anti-infective

Others

By Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

E-Pharmacy

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues analysis for each market segment.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Israel Pharmaceuticals Market Executive Summary
1.1. Israel Pharmaceuticals Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Type
1.3.2. By Product Type
1.3.3. By Application
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Israel Pharmaceuticals Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Israel Pharmaceuticals Market Dynamics
3.1. Market Drivers
3.1.1. Growing Prevalence of Chronic Diseases
3.1.2. Government Initiatives and Health Education Programs
3.1.3. Introduction of Health Insurance Policies
3.2. Market Challenges
3.2.1. Financial Hurdles for Consumers and Manufacturers
3.2.2. Competition from International Pharmaceutical Companies
3.3. Market Opportunities
3.3.1. Increasing Investments in R&D
3.3.2. Expanding Geriatric Population
3.3.3. Technological Advancements in Pharmaceutical Products
Chapter 4. Israel Pharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Israel Pharmaceuticals Market Size & Forecasts by Drug Type 2022-2032
5.1. Segment Dashboard
5.2. Israel Pharmaceuticals Market: Drug Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Generic Drugs
5.2.2. Branded Drugs
Chapter 6. Israel Pharmaceuticals Market Size & Forecasts by Product Type 2022-2032
6.1. Segment Dashboard
6.2. Israel Pharmaceuticals Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Over-The-Counter Drugs
6.2.2. Prescription Drugs
Chapter 7. Israel Pharmaceuticals Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Israel Pharmaceuticals Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Cardiovascular
7.2.2. Oncology
7.2.3. Metabolic Disorder
7.2.4. Musculoskeletal
7.2.5. Anti-infective
7.2.6. Others
Chapter 8. Israel Pharmaceuticals Market Size & Forecasts by Distribution Channel 2022-2032
8.1. Segment Dashboard
8.2. Israel Pharmaceuticals Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Retail Pharmacy
8.2.2. Hospital Pharmacy
8.2.3. E-Pharmacy
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Kamada Pharmaceuticals
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Kamada Pharmaceuticals
9.3.3. MediWound Ltd
9.3.4. Protalix BioTherapeutics Inc
9.3.5. Enlivex Therapeutics Ltd
9.3.6. Bonus BioGroup Ltd
9.3.7. Roche Pharmaceuticals (Israel) Ltd.
9.3.8. Rafa Laboratories Ltd.
9.3.9. Pfizer Pharmaceuticals Israel Ltd.
9.3.10. CytoReason
9.3.11. Dexcel Pharma
9.3.12. Pharmathen
9.3.13. Sanofi (Israel)
9.3.14. Novartis Israel
9.3.15. Merck Sharp & Dohme (Israel)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Israel Pharmaceuticals market, report scope
TABLE 2. Israel Pharmaceuticals market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Israel Pharmaceuticals market estimates & forecasts by Drug Type 2022-2032 (USD Billion)
TABLE 4. Israel Pharmaceuticals market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 5. Israel Pharmaceuticals market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 6. Israel Pharmaceuticals market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
…
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Israel Pharmaceuticals market, research methodology
FIGURE 2. Israel Pharmaceuticals market, market estimation techniques
FIGURE 3. Israel market size estimates & forecast methods
FIGURE 4. Israel Pharmaceuticals market, key trends 2023
FIGURE 5. Israel Pharmaceuticals market, growth prospects 2022-2032
FIGURE 6. Israel Pharmaceuticals market, porters 5 force model
FIGURE 7. Israel Pharmaceuticals market, PESTEL analysis
FIGURE 8. Israel Pharmaceuticals market, value chain analysis
FIGURE 9. Israel Pharmaceuticals market by Drug Type, 2022 & 2032 (USD Billion)
FIGURE 10. Israel Pharmaceuticals market by Product Type, 2022 & 2032 (USD Billion)
FIGURE 11. Israel Pharmaceuticals market by Application, 2022 & 2032 (USD Billion)
FIGURE 12. Israel Pharmaceuticals market by Distribution Channel, 2022 & 2032 (USD Billion)
FIGURE 20. Israel Pharmaceuticals market, company market share analysis (2023)
…
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us